NASDAQ
09.01.26 | 22:00
8,440 US-Dollar
-0,47 % -0,040
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Profound Medical Corp (2): Profound sees first Johns Hopkins Tulsa case | 1 | Stockwatch | ||
| Di | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| Di | Profound Medical Corp.: Johns Hopkins Medicine Treats First Commercial TULSA-PRO Case | 1 | GlobeNewswire (USA) | ||
| 30.12.25 | Profound Medical Corp. Announces Closing of Private Placement | 1.666 | GlobeNewswire (Europe) | TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company") is pleased to announce that it has completed its previously announced private... ► Artikel lesen | |
| PROFOUND MEDICAL Aktie jetzt für 0€ handeln | |||||
| 24.12.25 | Profound Medical increases private placement to $6.45M | 1 | Seeking Alpha | ||
| 24.12.25 | Profound Medical Corp. Announces Upsize of Private Placement | 292 | GlobeNewswire (Europe) | TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company") is pleased to announce that it has increased the size of its private placement... ► Artikel lesen | |
| 23.12.25 | Profound Medical Corp (2): Profound closes $36-million offering | 1 | Stockwatch | ||
| 23.12.25 | Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th | 140 | GlobeNewswire (Europe) | TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company") today announced the closing of its previously announced registered direct offering... ► Artikel lesen | |
| 19.12.25 | Profound Medical Corp (2): Profound arranges $40-million financing | 1 | Stockwatch | ||
| 19.12.25 | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 19.12.25 | Profound Medical prices $40M offering | 1 | MassDevice | ||
| 19.12.25 | Profound Medical announces pricing of up to $40 million financing | 1 | Seeking Alpha | ||
| 19.12.25 | Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement | 1 | GlobeNewswire (USA) | ||
| 04.12.25 | Profound Medical Corp.: Stanford Medicine's Dr. Pejman Ghanouni Receives RSNA's Cum Laude Award for CAPTAIN Perioperative Data Presentation | 1 | GlobeNewswire (USA) | ||
| 28.11.25 | Profound Medical Corp (2): Profound Medical to roll out Tulsa-AI BPH module | 1 | Stockwatch | ||
| 28.11.25 | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 28.11.25 | Profound Medical Corp.: Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO Clinical Data, at RSNA and SUO Meetings | 1 | GlobeNewswire (USA) | ||
| 18.11.25 | Profound Medical Corp.: Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease | 4 | GlobeNewswire (USA) | ||
| 13.11.25 | Profound Medical Corp. Profit Declines In Q3 | - | RTTNews | ||
| 13.11.25 | Profound Medical Corp. - 10-Q, Quarterly Report | - | SEC Filings |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 37,530 | -4,02 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| BETA BIONICS | 20,070 | -37,26 % | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary... ► Artikel lesen | |
| PROGYNY | 26,990 | -1,60 % | Progyny-Aktie: Truist Securities stuft auf 'Kaufen' hoch und verweist auf verbesserte Aussichten | ||
| ALIGNMENT HEALTHCARE | 20,780 | -0,81 % | Where Alignment Healthcare Stands With Analysts | ||
| LUMEXA IMAGING | 16,680 | -5,92 % | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO | ||
| HEARTFLOW | 33,140 | -0,99 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,400 | +0,27 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,040 | -0,48 % | Privia Health stock rating initiated at Outperform by RBC Capital | ||
| GENEDX | 135,45 | -1,47 % | GeneDx partners with Komodo Health to create comprehensive rare disease dataset | ||
| ADAPTHEALTH | 10,490 | -1,22 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| RXSIGHT | 8,840 | -7,63 % | RxSight Sees Q4 Revenue Above View; Names Mark Wilterding CFO | ||
| PROCEPT BIOROBOTICS | 32,830 | -4,79 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| CLEARPOINT NEURO | 14,910 | -2,61 % | ClearPoint Neuro schließt Zustimmungsvereinbarung zur Restrukturierung von IRRAS AB | ||
| INTELLIGENT BIO SOLUTIONS | 17,920 | +25,23 % | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | ||
| AIRSCULPT TECHNOLOGIES | 2,260 | +1,80 % | Airsculpt Technologies, Inc.: AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board | MIAMI BEACH, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen |
PROFOUND MEDICAL CORP gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 8,440 Euro und damit -0,47 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFOUND MEDICAL CORP finden Sie auf Wallstreet Online.